Skip to main content
. 2017 Nov 17;2017(11):CD005067. doi: 10.1002/14651858.CD005067.pub4

Comparison 54.

Paromomycin 15% + 10% urea (twice daily for 45 d) versus ILMA (weekly for up to 3 months)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Participants complete cure 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected
2 Recurrence 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected
3 Scarring 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected